The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients
S Verlohren, I Herraiz, O Lapaire, D Schlembach… - American journal of …, 2012 - Elsevier
OBJECTIVE: The soluble fms-like tyrosine kinase (sFlt-1)/placental growth factor (PlGF) ratio
is a reliable tool in the assessment of preeclampsia. We tested the hypothesis that the sFlt …
is a reliable tool in the assessment of preeclampsia. We tested the hypothesis that the sFlt …
Use of serum and urinary soluble sFlt-1 and PLGF in the diagnosis of preeclampsia
P Tang, J Xu, B Xie, Q Wang - Hypertension in pregnancy, 2017 - Taylor & Francis
Objective: Preeclampsia (PE) is a disorder of pregnancy marked by hypertension and
proteinuria with no known treatment aside from pregnancy termination. The pathogenesis of …
proteinuria with no known treatment aside from pregnancy termination. The pathogenesis of …
The importance of repeated measurements of the sFlt-1/PlGF ratio for the prediction of preeclampsia and intrauterine growth restriction
K Schoofs, U Grittner, T Engels, J Pape… - Journal of perinatal …, 2014 - degruyter.com
Abstract Aims: The sFlt-1/PlGF ratio has been evaluated as a diagnostic marker for
preeclampsia (PE). The aim of this study was to explore the use of the sFlt-1/PlGF ratio as an …
preeclampsia (PE). The aim of this study was to explore the use of the sFlt-1/PlGF ratio as an …
sFlt‐1/PlGF ratio as a predictive and prognostic marker for preeclampsia
HR Jeon, DH Jeong, JY Lee, EY Woo… - Journal of Obstetrics …, 2021 - Wiley Online Library
Objective Preeclampsia is clinically unpredictable and associated with adverse outcomes.
Pregnant women with suspected preeclampsia require intensive monitoring or …
Pregnant women with suspected preeclampsia require intensive monitoring or …
An intermediate sFlt-1/PlGF ratio indicates an increased risk for adverse pregnancy outcome
J Hoffmann, V Ossada, M Weber, H Stepan - Pregnancy hypertension, 2017 - Elsevier
Abstract Objective: The sFlt-1/PlGF ratio is a valid marker in diagnosing or excluding
preeclampsia. The currently used cut offs frame an intermediate zone of 33–85 (< 34 0 …
preeclampsia. The currently used cut offs frame an intermediate zone of 33–85 (< 34 0 …
[HTML][HTML] Evaluation of angiogenic factors (PlGF and sFlt-1) in pre-eclampsia diagnosis
CPN Sá, MF Jiménez, MW Rosa, EM Arlindo… - Revista Brasileira de …, 2020 - SciELO Brasil
Objective: Recent observations support the hypothesis that an imbalance between
angiogenic factors has a fundamental role in the pathogenesis of pre-eclampsia and is …
angiogenic factors has a fundamental role in the pathogenesis of pre-eclampsia and is …
SFLT-1/PLGF RATIO AND HYPERTENSIVE STATES OF PREGNANCY IN REAL LIFE: ANALYSING RISK OF PREECLMAPSIA
E Martínez-morales, CM Rodriguez… - Journal of …, 2024 - journals.lww.com
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved. Page 1 Abstracts e315 Design
and method: We conducted a cross- sectional study which included women who delivered …
and method: We conducted a cross- sectional study which included women who delivered …
[HTML][HTML] A cross sectional study to assess the sFlt-1: PlGF ratio in pregnant women with and without preeclampsia
Background Preeclampsia is a multisystem disorder characterized by vascular endothelial
malfunction occurring after 20 weeks of gestation. Placental soluble fms-like tyrosine kinase …
malfunction occurring after 20 weeks of gestation. Placental soluble fms-like tyrosine kinase …
The sFlt-1/PlGF ratio associates with prolongation and adverse outcome of pregnancy in women with (suspected) preeclampsia: analysis of a high-risk cohort
L Saleh, K Verdonk, AHJ Danser, EAP Steegers… - European Journal of …, 2016 - Elsevier
Objective To evaluate the additive value of the sFlt-1/PlGF ratio for diagnosing preeclampsia
(PE) and predicting prolongation of pregnancy and adverse outcome in a cohort of women …
(PE) and predicting prolongation of pregnancy and adverse outcome in a cohort of women …